Learn how a promotional asset moves from development and internal review through PAAB submission, review, revision, and preclearance in Canada.
SciNarris is an independent educational platform and is not affiliated with, endorsed by, sponsored by, or otherwise associated with the Pharmaceutical Advertising Advisory Board (PAAB) or Health Canada.
This module is provided for educational purposes only. It is intended to help medical writers and other learners understand the PAAB submission and preclearance ecosystem. It does not constitute official PAAB guidance, regulatory advice, legal advice, or professional advice. For current requirements, interpretations, and official guidance, always refer directly to PAAB and Health Canada.
PAAB (Pharmaceutical Advertising Advisory Board) preclearance is the independent advisory review process administered under the Canadian Code of Advertising Acceptance. When preclearance is required, promotional healthcare communications directed to Canadian healthcare professionals or consumers must achieve formal PAAB acceptance before public dissemination.
“Imagine you are a medical writer. A brand team asks you to develop a promotional email for a healthcare professional audience. What happens between ‘Let’s create this asset’ and the point at which the material can be used in the Canadian market?”
Before a promotional communication reaches Canadian physicians, pharmacists, or patients, it progresses through a defined multi-step journey:
PAAB submission is never the first step in creating a promotional campaign. Before any package goes to PAAB, the sponsor team and medical writer build and audit the material internally:
Promotional claims must align strictly with the Health Canada-authorized Canadian Product Monograph (PM/CPM), which defines approved indications, dosage, and safety parameters.
The medical writer identifies high-quality clinical evidence (peer-reviewed human trials) and prepares highlighted PDF publications with precise line citations.
The manufacturer’s internal Medical, Legal, Regulatory (MLR), and Compliance team audits the piece for scientific accuracy, trademark protection, and brand strategy.
Once the promotional material is ready for submission, the submission package may contain several documents and supporting materials. The exact requirements can vary depending on the type of submission and the circumstances, so always check the current PAAB guidance.
A document providing context for the submission and identifying relevant information for the reviewer.
The written version of the promotional material, including promotional messaging and reference support.
The designed version of the promotional material showing how the copy, visuals, disclosures, and other elements appear in the final material.
The applicable authorized product information used as an important reference point when developing and reviewing promotional content.
References in which the relevant sections supporting promotional messages are identified/highlighted and labelled so that the reviewer can trace the claims/messages back to their evidence.
Supporting source documents provided as required for the submission. Under PAAB references guidelines, references associated with a piece are submitted as separate, complete, legible, searchable, and logically named PDF files.
When comments are received, the response and revised material may become part of the subsequent review/resubmission workflow.
Additional documents may be required depending on the material and submission circumstances.
Source note: Submission requirements can change and may differ by submission type. For current requirements, refer to the official PAAB Submissions Guidance Document and the PAAB References Checklist .
In promotional medical writing, every claim must be backed by appropriate data. Consider a typical copywriting example:
Question: “What specific evidence supports this exact wording?”
The specific promotional headline or efficacy statement.
The underlying clinical study data and statistical proof.
The precise publication citation and highlighted line reference.
Precision Phrasing: Professional medical writers avoid stating that they “prove the claim.” Instead, writers ensure that the data supports the claim, substantiates the claim, or supports the specific wording.
Once the electronic package is uploaded to PAAB, the material undergoes formal evaluation:
PAAB receives the submission package and assigns an advisory reviewer.
The reviewer evaluates promotional claims, Product Monograph alignment, fair balance, and reference citations against Code standards.
PAAB issues first-turn comments detailing required copy edits, reference requests, or layout adjustments.
The sponsor team and medical writer prepare a point-by-point response rationale and updated layout files.
The revised package is resubmitted to PAAB for confirmation.
Upon meeting Code criteria, PAAB grants formal acceptance and issues a clearance letter.
Medical writers are key contributors across all three phases of the submission life cycle:
Consider a practical workplace scenario when PAAB issues reviewer comments:
After reviewer comments are analyzed and copy adjustments are agreed upon, the medical writer and regulatory team execute the revision workflow:
Logging every PAAB comment and internal response decision in a master tracking sheet.
Drafting point-by-point scientific explanations for each reviewer query.
Updating layout copy decks and graphic mockups to incorporate required revisions.
Adding new publication references or updating highlighted line citations.
Maintaining strict version numbering (e.g. V1.0 to V2.0) across all documents.
Verifying that all reviewer comments have been addressed before resubmission.
Note: Submission revision workflows vary depending on the submission class, number of comment turns, and asset complexity.
Preclearance represents external verification that applicable promotional communications comply with PAAB Code standards:
Conducted by the pharmaceutical sponsor’s internal medical, legal, and regulatory team to confirm brand strategy, medical accuracy, and company policy prior to external submission.
The external advisory review process operated by PAAB against applicable PAAB Code requirements, resulting in formal PAAB acceptance and a clearance registration letter.
Test your understanding of the medical writer’s preclearance sequence:
Scenario: A medical writer has drafted a promotional HCP email. Which sequence best represents the overall submission and preclearance journey?
Navigate specific resource modules for deeper learning across PAAB copywriting, claims substantiation, and review mechanics:
Learn how promotional claims, references, and fair balance disclosures are structured objectively without unanchored superlatives or therapeutic exaggeration.
Understanding the step-by-step preclearance workflow from draft copy to PAAB acceptance.
Assembling Product Monographs, line references, and submission documents.
Substantiating therapeutic claims with trial data and citation precision.
Structuring benefit statements and risk disclosures in Canadian promotion.
Analyzing PAAB letter comments and preparing effective scientific responses.
Managing layout revisions and citation updates during review turns.
Distinguishing HCP promotional assets from exempt scientific communications.
Deep dive into internal sponsor review versus external PAAB advisory clearance.
Real-world copywriting scenarios, comment resolution, and final preclearance.
Answers to common questions about PAAB submissions, preclearance workflows, and the medical writer’s role:
A PAAB submission is the formal process of sending healthcare advertising and promotional materials (such as HCP detail aids, e-blasts, journal ads, or patient brochures) to the Pharmaceutical Advertising Advisory Board for review prior to publication or dissemination in Canada.
PAAB preclearance is the external advisory review process conducted by PAAB reviewers under the PAAB Code of Advertising Acceptance. When preclearance is required by the Code, promotional materials must achieve formal PAAB acceptance before they can be released to Canadian healthcare professionals or consumers.
Preclearance is a PAAB Code requirement for advertising within the Code's scope unless explicitly exempted (such as certain non-promotional medical education or context-specific exempt communications). Health Canada does not universally mandate PAAB preclearance for all materials except under specific regulatory circumstances or directives.
Medical writers develop code-aligned promotional copy, verify that every therapeutic claim is backed by valid clinical data from the authorized Product Monograph or published trials, assemble highlighted PDF reference packages with line citations, assist in responding to PAAB reviewer comments, and maintain version control across revisions.
Internal MLR (Medical, Legal, Regulatory) review is conducted by the pharmaceutical company's internal cross-functional team to check brand alignment, medical accuracy, legal liability, and corporate compliance before external submission. External PAAB review evaluates applicable promotional pieces against standardized PAAB Code requirements to grant independent preclearance.
When PAAB issues first-turn comments or questions, the sponsor team and medical writer evaluate the feedback, check whether claim wording needs adjustment, prepare a clear point-by-point response letter, revise the copy and reference package, and resubmit the updated files to PAAB.
Official PAAB submission guidelines, advisories, fee schedules, and the digital Code of Advertising Acceptance are available directly on official PAAB websites at paab.ca and code.paab.ca.
For authoritative regulatory requirements, official advisories, fee schedules, and current Code provisions, refer to official PAAB and Health Canada sources:
Official PAAB portal, announcements & e-file.
PAAB CODEcode.paab.caCode of Advertising Acceptance standards.
PAAB SERVICESpaab.ca/servicesReview turnaround schedules & fee tiers.
SUBMISSION GUIDANCEPAAB Submissions DocumentOfficial documentation package rules.
CODE PRECLEARANCE RULEPreclearance AdvisoryOfficial preclearance scope clarification.
HEALTH CANADAcanada.caFederal advertising regulatory framework.
Step back into the PAAB Learning Pathway for a structured introduction to Canadian healthcare promotion and PAAB preclearance concepts.
SciNarris is an independent educational resource and is not affiliated with, endorsed by, or partnered with PAAB or Health Canada.